These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2760170)

  • 21. The response of serum growth hormone levels to the long-acting somatostatin analog SMS 201-995 in acromegaly.
    Comi RJ; Gorden P
    J Clin Endocrinol Metab; 1987 Jan; 64(1):37-42. PubMed ID: 2878009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.
    Lamberts SW; Oosterom R; Neufeld M; del Pozo E
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1161-5. PubMed ID: 2860119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in cholecystokinin release and gallbladder contraction between emulsified and nonemulsified long-chain triglycerides.
    Ledeboer M; Masclee AA; Biemond I; Lamers CB
    JPEN J Parenter Enteral Nutr; 1999; 23(4):203-6. PubMed ID: 10421388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effect of octreotide in acromegaly on insulin resistance.
    Breidert M; Pinzer T; Wildbrett J; Bornstein SR; Hanefeld M
    Horm Metab Res; 1995 May; 27(5):226-30. PubMed ID: 7642173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
    Quabbe HJ; Plöckinger U
    J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of SMS 201-995 on basal and stimulated pancreatic secretion in rats.
    Guan D; Maouyo D; Sarfati P; Morisset J
    Endocrinology; 1990 Jul; 127(1):298-304. PubMed ID: 2361474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute effect of small dosages of somatostatin analogue SMS201-995 on gallbladder contractility in normal adults].
    Zhu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Jun; 14(3):201-5. PubMed ID: 1394739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term treatment of acromegaly with the somatostatin analog octreotide (Sandostatin). On the predictive significance of acute tests].
    Schmidt K; Althoff PH; Harris A; Hofmeister-Wagner W; Schifferdecker E; Schöffling K
    Med Klin (Munich); 1990 Dec; 85(12):700-6. PubMed ID: 2128367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prospective study of functional changes in the gallbladder and formation of gallstones induced by long-term treatment of somatostatin analogue SMS201-995 in patients of active acromegaly].
    Zhu XF; Shi YF; Zhang JX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):405-8, 455. PubMed ID: 1752152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of acromegaly with long acting somatostatin analogue SMS 201-995.
    Horikawa R; Takano K; Hizuka N; Asakawa K; Sukegawa I; Hirose N; Horiba N; Kasono K; Masuda A; Ohba Y
    Endocrinol Jpn; 1988 Oct; 35(5):741-51. PubMed ID: 3220051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly.
    Stewart PM; Kane KF; Stewart SE; Lancranjan I; Sheppard MC
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3267-72. PubMed ID: 7593436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group.
    Sassolas G; Harris AG; James-Deidier A
    J Clin Endocrinol Metab; 1990 Aug; 71(2):391-7. PubMed ID: 2199479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans.
    Thimister PW; Hopman WP; Tangerman A; Rosenbusch G; Willems HL; Jansen JB
    Hepatology; 1998 Dec; 28(6):1454-60. PubMed ID: 9828206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SMS 201-995 and thyroid function in acromegaly: acute, intermediate and long-term effects.
    Christensen SE; Weeke J; Kaal A; Harris AG; Orskov H
    Horm Metab Res; 1992 May; 24(5):237-9. PubMed ID: 1398464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
    Lamberts SW; Zweens M; Verschoor L; del Pozo E
    J Clin Endocrinol Metab; 1986 Jul; 63(1):16-9. PubMed ID: 2872225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elemental diet stimulates gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide in man.
    Hopman WP; de Jong AJ; Rosenbusch G; Jansen JB; Lamers CB
    Dig Dis Sci; 1987 Jan; 32(1):45-9. PubMed ID: 3539560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed plasma cholecystokinin and gallbladder responses to intestinal fat in patients with Billroth I and II gastrectomy.
    Masclee AA; Jansen JB; Driessen WM; Geuskens LM; Lamers CB
    Surgery; 1989 Sep; 106(3):502-8. PubMed ID: 2772825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.